Pancreatic Cancer

As a pancreatic cancer survivor, I realized how important it is to help others who are in the throes of their cancer experience.

From the death of “Schitt’s Creek” Emmy winning-producer “Ben Feigin” to “Good Charlotte” signer Joel Madden donating nearly $200,000 to an osteosarcoma nonprofit, here’s what’s happening in the cancer space this week.

The novel drug PY159 will be studied as a single agent and in combination with Keytruda for patients with certain solid tumors — including ovarian, pancreatic, lung, head and neck, colorectal and breast cancers.

Receiving a pancreatic cancer diagnosis has caused me to reexamine my spirituality, which led me to believe that my life is a line, rather than a single dot in time.

Treatment with FOLFIRINOX, a combination of several chemotherapy agents, prior to the surgical resection of pancreatic cancer increased survival outcomes when compared to historical data.

The first patient enrolled onto a phase 1 trial has received TCMB07, an investigational drug, for the treatment of cachexia, a severe disorder that may occur in more than half of patients with advanced-stage cancer.

The use of a chemotherapy-free, combination regimen as a maintenance treatment option was associated with an improvement in survival in a group of patients with advanced pancreatic cancer.

According to the manufacturer, this is the first-in-human clinical trial of Allocetra combined with chemotherapy in patients with peritoneal metastases arising from solid cancers.

The addition of nimotuzumab to a treatment regimen of the chemotherapy gemcitabine improved overall survival in patients with KRAS wild-type advanced pancreatic cancer.

As I go in for another cancer follow-up, I need to remind myself that what could happen is different from what would happen.

Four sites across the United States are enrolling patients with locally advanced or metastatic pancreatic cancer to see if a novel drug combined with standard-of-care chemotherapy bests chemotherapy alone in survival outcomes and responses to treatment.

The study authors plan to enroll 32 patients with advanced pancreatic cancer into the trial to assess the efficacy and safety of an experimental treatment combination.

Single-agent adagrasib was associated with encouraging treatment responses in patients with previously treated non-colorectal gastrointestinal tumors and pancreatic ductal adenocarcinoma.

Researchers plan to enroll 60 patients in the first-in-human phase 1 clinical trial to assess the safety and preliminary clinical activity of an anti-CD39 monoclonal antibody to treat advanced solid tumors.

This study is the first to evaluate this rising trend of pancreatic cancer incidence in women under the age of 55.

A pancreatic cancer survivor explains why he chose to undergo genetic testing and what he learned from the experience.

Study results showed that CPI-613 did not improve survival in patients with metastatic adenocarcinoma of the pancreas.

Celsion GmbH has initiated a phase 1 trial to analyze ThermoDox with focused ultrasound for patients with pancreatic cancer.

A cancer survivor shares how to appreciate the good moments and lean on others during cancer. “My dire situation brought out the best of those around me,” he writes.

There’s a tremendous amount of interest in immunotherapy drugs given alongside targeted therapies for patients with pancreatic cancer, according to an expert.

From “Sex and the City” star and “real-life Tarzan” dying to a man planning to swim the English Channel to raise cancer funds, here is what is happening in the cancer space this week.

GC4419 plus radiation improved progression-free survival and time to distant metastases in patients with unresectable or borderline resectable locally advanced pancreatic cancer.

Cancer survivors share a unique connection. In this post, a survivor writes about meeting a stranger with stage 4 cancer who had an incredible impact on him.

From actor Rick Aiello’s death due cancer to the FDA approval of a medication to treat lymphoma in dogs, here’s what’s happening in the cancer landscape this week.

Increasingly, researchers are playing matchmaker between patients with metastatic cancer and targeted drugs via studies called basket trials.

A survivor of pancreatic cancer looks back on the day he received his diagnosis, and shares advice for others in the same shoes.

A pancreatic cancer survivor explains how gardening helps him feel at peace.

From Georgia Congressman John Lewis receiving a tribute from the American Cancer Society to Sheryl Crow urging people to resume regular health and wellness screenings, here’s what’s happening in the cancer landscape this week.

A cancer survivor and former military service member writes how he used to be short with people, demanded things be done his way and often made others feel little — that is until his cancer diagnosis. Here, he shares how his experience with cancer taught him to be kinder to others.

From a 12-year-old girl living out her dream of living on the beach after 10 years of neuroblastoma treatments to Alex Trebek’s legacy living on after his passing, here’s what’s happening in the cancer space this week.